Virtu Financial’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
AI
Virtu Financial's CRL Position: Q4 2025 in Review
Virtu Financial sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 2,175 shares — an estimated $340K sold.
Virtu Financial first reported a position in CRL in Q2 2015 and held it in 11 quarters. The position peaked at $1.19M in Q2 2022. 580 funds tracked by Wall St. Rank hold CRL as of Q4 2025.
- Virtu Financial reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
- Virtu Financial sold 2,175 Charles River Laboratories shares in Q4 2025, an estimated $340K.
- Virtu Financial first reported a position in Charles River Laboratories in Q2 2015 and held it in 11 quarters.
- Virtu Financial's Charles River Laboratories position peaked at $1.19M in Q2 2022.
- 580 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.
Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.